Stand B13-A14

2023 Edition



Traumatic spinal cord injury is a huge unmet need for which there is no therapeutic solution. Medjeduse develops a proprietary biomaterial (Chitosan form) as a neurosurgical medical implant to heal spinal cord injuries that cause locomotor and sensory loss. A proof of concept has been achieved in rat preclinical models. A larger animal study in pigs is ongoing before executing a first-in-human clinical trial

Scroll to Top
  • No products in the cart.